Re: School district cited in suit over suicide - From TheNewsTribune.com

[Guest guest]

the CEO of Forest Pharmaceuticals, , has a son who wrote a

book The Noonday Demon: An Atlas of Depression I tried to read it, but because

of the idea of hailing the miracles of antidepressants I returned it to the

library, then googled and found out who he was.

" in 1994 when CEO 's son fell into a deep depression.

began researching treatments for his son and discovered a European

antidepressant named Cipramil, which had been developed by the Danish company H.

Lundbeck A/S. Cipramil had achieved market share in Europe of more than 40

percent mainly because it was considered to have fewer side effects than the

U.S. blockbusters Prozac (Eli Lilly and Company) and Zoloft (Pfizer Inc.) The

head of Lundbeck had tried to license the drug to several large U.S. drug

companies, but each deal fell through--the companies apparently having concluded

that Cipramil's sales potential was not large enough for them. For Forest,

however, Cipramil was a perfect fit, and so signed a deal with Lundbeck

in early 1996 to license the drug for sale in the United States under the name

Celexa. "

" After learning about the drug (known in Europe as Cipramil) while researching

treatments for , was eager to speak with the head of H. Lundbeck,

the Danish company that had developed it. At that point, though, CEO

Sprunk-Jansen had all but given up trying to sell Cipramil in the U.S. He had

signed licensing agreements with no fewer than three big U.S. pharmaceutical

companies, only to watch each collapse. Sprunk-Jansen " was very cool to the idea

of dealing with another company, " says .

So one day in mid-1995, called from New York, led Sprunk-Jansen to

believe he was in Copenhagen, and casually suggested he stop by sometime.

Sprunk-Jansen invited him to lunch the next day. flew over on the

Concorde. During the meeting, mentioned that he was a member of the

board of directors of the New York City Ballet: Sprunk-Jansen has a great

interest in ballet, and the NYCB's ballet-master-in-chief just happens to be

another Dane, s. arranged for Sprunk-Jansen and his wife to

attend a performance in New York and meet s afterward. During one dinner

on their trip, Sprunk-Jansen's wife, Randi Kindem, who had run Lundbeck's

subsidiary in Norway, calculated on a napkin how much Cipramil might earn in the

U.S. if it proved as popular as it was in Sweden, where it had a 50% market

share. " When saw the numbers, he almost fainted, " says Sprunk-Jansen.

was someone he could work with. In early 1996, they signed a deal. "

http://www.businessweek.com/magazine/content/02_21/b3784001.htm

http://www.answers.com/topic/forest-laboratories-inc?cat=biz-fin

http://www.noondaydemon.com/biography.html

School district cited in suit over suicide - From

TheNewsTribune.com

Message http://www.thenewstribune.com/news/local/story/247022.html

Forest Pharmaceuticals is accused of failing to warn the nurse practitioner

that Lexapro could enhance the risk of suicide in teenage patients, and that

April's worsening symptoms were caused at least in part by the drug. The nurse

practitioner is accused of failing to take appropriate action to protect the

teen.

[Guest guest]

the CEO of Forest Pharmaceuticals, , has a son who wrote a

book The Noonday Demon: An Atlas of Depression I tried to read it, but because

of the idea of hailing the miracles of antidepressants I returned it to the

library, then googled and found out who he was.

" in 1994 when CEO 's son fell into a deep depression.

began researching treatments for his son and discovered a European

antidepressant named Cipramil, which had been developed by the Danish company H.

Lundbeck A/S. Cipramil had achieved market share in Europe of more than 40

percent mainly because it was considered to have fewer side effects than the

U.S. blockbusters Prozac (Eli Lilly and Company) and Zoloft (Pfizer Inc.) The

head of Lundbeck had tried to license the drug to several large U.S. drug

companies, but each deal fell through--the companies apparently having concluded

that Cipramil's sales potential was not large enough for them. For Forest,

however, Cipramil was a perfect fit, and so signed a deal with Lundbeck

in early 1996 to license the drug for sale in the United States under the name

Celexa. "

" After learning about the drug (known in Europe as Cipramil) while researching

treatments for , was eager to speak with the head of H. Lundbeck,

the Danish company that had developed it. At that point, though, CEO

Sprunk-Jansen had all but given up trying to sell Cipramil in the U.S. He had

signed licensing agreements with no fewer than three big U.S. pharmaceutical

companies, only to watch each collapse. Sprunk-Jansen " was very cool to the idea

of dealing with another company, " says .

So one day in mid-1995, called from New York, led Sprunk-Jansen to

believe he was in Copenhagen, and casually suggested he stop by sometime.

Sprunk-Jansen invited him to lunch the next day. flew over on the

Concorde. During the meeting, mentioned that he was a member of the

board of directors of the New York City Ballet: Sprunk-Jansen has a great

interest in ballet, and the NYCB's ballet-master-in-chief just happens to be

another Dane, s. arranged for Sprunk-Jansen and his wife to

attend a performance in New York and meet s afterward. During one dinner

on their trip, Sprunk-Jansen's wife, Randi Kindem, who had run Lundbeck's

subsidiary in Norway, calculated on a napkin how much Cipramil might earn in the

U.S. if it proved as popular as it was in Sweden, where it had a 50% market

share. " When saw the numbers, he almost fainted, " says Sprunk-Jansen.

was someone he could work with. In early 1996, they signed a deal. "

http://www.businessweek.com/magazine/content/02_21/b3784001.htm

http://www.answers.com/topic/forest-laboratories-inc?cat=biz-fin

http://www.noondaydemon.com/biography.html

School district cited in suit over suicide - From

TheNewsTribune.com

Message http://www.thenewstribune.com/news/local/story/247022.html

Forest Pharmaceuticals is accused of failing to warn the nurse practitioner

that Lexapro could enhance the risk of suicide in teenage patients, and that

April's worsening symptoms were caused at least in part by the drug. The nurse

practitioner is accused of failing to take appropriate action to protect the

teen.

[Guest guest]

the CEO of Forest Pharmaceuticals, , has a son who wrote a

book The Noonday Demon: An Atlas of Depression I tried to read it, but because

of the idea of hailing the miracles of antidepressants I returned it to the

library, then googled and found out who he was.

" in 1994 when CEO 's son fell into a deep depression.

began researching treatments for his son and discovered a European

antidepressant named Cipramil, which had been developed by the Danish company H.

Lundbeck A/S. Cipramil had achieved market share in Europe of more than 40

percent mainly because it was considered to have fewer side effects than the

U.S. blockbusters Prozac (Eli Lilly and Company) and Zoloft (Pfizer Inc.) The

head of Lundbeck had tried to license the drug to several large U.S. drug

companies, but each deal fell through--the companies apparently having concluded

that Cipramil's sales potential was not large enough for them. For Forest,

however, Cipramil was a perfect fit, and so signed a deal with Lundbeck

in early 1996 to license the drug for sale in the United States under the name

Celexa. "

" After learning about the drug (known in Europe as Cipramil) while researching

treatments for , was eager to speak with the head of H. Lundbeck,

the Danish company that had developed it. At that point, though, CEO

Sprunk-Jansen had all but given up trying to sell Cipramil in the U.S. He had

signed licensing agreements with no fewer than three big U.S. pharmaceutical

companies, only to watch each collapse. Sprunk-Jansen " was very cool to the idea

of dealing with another company, " says .

So one day in mid-1995, called from New York, led Sprunk-Jansen to

believe he was in Copenhagen, and casually suggested he stop by sometime.

Sprunk-Jansen invited him to lunch the next day. flew over on the

Concorde. During the meeting, mentioned that he was a member of the

board of directors of the New York City Ballet: Sprunk-Jansen has a great

interest in ballet, and the NYCB's ballet-master-in-chief just happens to be

another Dane, s. arranged for Sprunk-Jansen and his wife to

attend a performance in New York and meet s afterward. During one dinner

on their trip, Sprunk-Jansen's wife, Randi Kindem, who had run Lundbeck's

subsidiary in Norway, calculated on a napkin how much Cipramil might earn in the

U.S. if it proved as popular as it was in Sweden, where it had a 50% market

share. " When saw the numbers, he almost fainted, " says Sprunk-Jansen.

was someone he could work with. In early 1996, they signed a deal. "

http://www.businessweek.com/magazine/content/02_21/b3784001.htm

http://www.answers.com/topic/forest-laboratories-inc?cat=biz-fin

http://www.noondaydemon.com/biography.html

School district cited in suit over suicide - From

TheNewsTribune.com

Message http://www.thenewstribune.com/news/local/story/247022.html

Forest Pharmaceuticals is accused of failing to warn the nurse practitioner

that Lexapro could enhance the risk of suicide in teenage patients, and that

April's worsening symptoms were caused at least in part by the drug. The nurse

practitioner is accused of failing to take appropriate action to protect the

teen.

[Guest guest]

the CEO of Forest Pharmaceuticals, , has a son who wrote a

book The Noonday Demon: An Atlas of Depression I tried to read it, but because

of the idea of hailing the miracles of antidepressants I returned it to the

library, then googled and found out who he was.

" in 1994 when CEO 's son fell into a deep depression.

began researching treatments for his son and discovered a European

antidepressant named Cipramil, which had been developed by the Danish company H.

Lundbeck A/S. Cipramil had achieved market share in Europe of more than 40

percent mainly because it was considered to have fewer side effects than the

U.S. blockbusters Prozac (Eli Lilly and Company) and Zoloft (Pfizer Inc.) The

head of Lundbeck had tried to license the drug to several large U.S. drug

companies, but each deal fell through--the companies apparently having concluded

that Cipramil's sales potential was not large enough for them. For Forest,

however, Cipramil was a perfect fit, and so signed a deal with Lundbeck

in early 1996 to license the drug for sale in the United States under the name

Celexa. "

" After learning about the drug (known in Europe as Cipramil) while researching

treatments for , was eager to speak with the head of H. Lundbeck,

the Danish company that had developed it. At that point, though, CEO

Sprunk-Jansen had all but given up trying to sell Cipramil in the U.S. He had

signed licensing agreements with no fewer than three big U.S. pharmaceutical

companies, only to watch each collapse. Sprunk-Jansen " was very cool to the idea

of dealing with another company, " says .

So one day in mid-1995, called from New York, led Sprunk-Jansen to

believe he was in Copenhagen, and casually suggested he stop by sometime.

Sprunk-Jansen invited him to lunch the next day. flew over on the

Concorde. During the meeting, mentioned that he was a member of the

board of directors of the New York City Ballet: Sprunk-Jansen has a great

interest in ballet, and the NYCB's ballet-master-in-chief just happens to be

another Dane, s. arranged for Sprunk-Jansen and his wife to

attend a performance in New York and meet s afterward. During one dinner

on their trip, Sprunk-Jansen's wife, Randi Kindem, who had run Lundbeck's

subsidiary in Norway, calculated on a napkin how much Cipramil might earn in the

U.S. if it proved as popular as it was in Sweden, where it had a 50% market

share. " When saw the numbers, he almost fainted, " says Sprunk-Jansen.

was someone he could work with. In early 1996, they signed a deal. "

http://www.businessweek.com/magazine/content/02_21/b3784001.htm

http://www.answers.com/topic/forest-laboratories-inc?cat=biz-fin

http://www.noondaydemon.com/biography.html

School district cited in suit over suicide - From

TheNewsTribune.com

Message http://www.thenewstribune.com/news/local/story/247022.html

Forest Pharmaceuticals is accused of failing to warn the nurse practitioner

that Lexapro could enhance the risk of suicide in teenage patients, and that

April's worsening symptoms were caused at least in part by the drug. The nurse

practitioner is accused of failing to take appropriate action to protect the

teen.

[Guest guest]

so Cipramil is Celexa in the states.

Another book written about the wonders of pharmaceuticals with a familiar

link back to the

company selling the drug. Interesting.

School district cited in suit over suicide -

From TheNewsTribune.com

Message http://www.thenewstribune.com/news/local/story/247022.html

Forest Pharmaceuticals is accused of failing to warn the nurse

practitioner that Lexapro could enhance the risk of suicide in teenage

patients, and that April's worsening symptoms were caused at least in part

by the drug. The nurse practitioner is accused of failing to take

appropriate action to protect the teen.

[Guest guest]

so Cipramil is Celexa in the states.

Another book written about the wonders of pharmaceuticals with a familiar

link back to the

company selling the drug. Interesting.

School district cited in suit over suicide -

From TheNewsTribune.com

Message http://www.thenewstribune.com/news/local/story/247022.html

Forest Pharmaceuticals is accused of failing to warn the nurse

practitioner that Lexapro could enhance the risk of suicide in teenage

patients, and that April's worsening symptoms were caused at least in part

by the drug. The nurse practitioner is accused of failing to take

appropriate action to protect the teen.

[Guest guest]

so Cipramil is Celexa in the states.

Another book written about the wonders of pharmaceuticals with a familiar

link back to the

company selling the drug. Interesting.

School district cited in suit over suicide -

From TheNewsTribune.com

Message http://www.thenewstribune.com/news/local/story/247022.html

Forest Pharmaceuticals is accused of failing to warn the nurse

practitioner that Lexapro could enhance the risk of suicide in teenage

patients, and that April's worsening symptoms were caused at least in part

by the drug. The nurse practitioner is accused of failing to take

appropriate action to protect the teen.

[Guest guest]

so Cipramil is Celexa in the states.

Another book written about the wonders of pharmaceuticals with a familiar

link back to the

company selling the drug. Interesting.

School district cited in suit over suicide -

From TheNewsTribune.com

Message http://www.thenewstribune.com/news/local/story/247022.html

Forest Pharmaceuticals is accused of failing to warn the nurse

practitioner that Lexapro could enhance the risk of suicide in teenage

patients, and that April's worsening symptoms were caused at least in part

by the drug. The nurse practitioner is accused of failing to take

appropriate action to protect the teen.